BMS-986325
- Generic Name
- BMS-986325
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 25
- Registration Number
- NCT05813717
- Locations
- 🇺🇸
Local Institution - 0001, Cypress, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath